Back
Intellia Therapeutics Vs. Exponent Industry Stock Comparison
Sell
43
NTLA
Intellia Therapeutics
Last Price:
22.97
Seasonality Move:
37.64%
Buy
56
EXPO
Exponent
Last Price:
94.16
Seasonality Move:
4.98%
Sell
43
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $23.90. The Score for NTLA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Exponent (EXPO)
is a Buy
Is Exponent a Buy, Sell or Hold?
- The current Exponent [EXPO] share price is $94.78. The Score for EXPO is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- EXPO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $23.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.62 | Sell |
| Relative Strength Index (14 RSI): | 52.63 | Buy |
| Chaikin Money Flow: | 456982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.33 - 24.69) | Buy |
| Bollinger Bands (100): | (23.82 - 30.08) | Sell |
EXPO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 73.23 | Buy |
| Chaikin Money Flow: | -124539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (77.14 - 90.58) | Buy |
| Bollinger Bands (100): | (78.01 - 88.91) | Buy |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.64 | Buy |
| 20-day SMA: | 22.46 | Buy |
| 50-day SMA: | 25.91 | Sell |
| 200-day SMA: | 29.87 | Sell |
| 8-day EMA: | 22.97 | Buy |
| 20-day EMA: | 23.08 | Buy |
| 50-day EMA: | 24.73 | Sell |
| 200-day EMA: | 30.11 | Sell |
EXPO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.53 | Buy |
| 20-day SMA: | 84.85 | Buy |
| 50-day SMA: | 82.01 | Buy |
| 200-day SMA: | 84.2 | Buy |
| 8-day EMA: | 91.91 | Buy |
| 20-day EMA: | 87.3 | Buy |
| 50-day EMA: | 83.86 | Buy |
| 200-day EMA: | 85.09 | Buy |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.01 per share.
Exponent Earnings Growth & EXPO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.05 per share, and an increase next year of $0.12 per share.
Intellia Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exponent Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||